SlideShare una empresa de Scribd logo
1 de 10
Descargar para leer sin conexión
3077463-
Metabolomics-based translationalMetabolomics-based translational
biomarkers for Alzheimer’s Diseasebiomarkers for Alzheimer’s Disease
Eugenia Trushina, PhDEugenia Trushina, PhD
Mayo Clinic RochesterMayo Clinic Rochester
June 17, 2013June 17, 2013
3077463-
MetabolomicsMetabolomics
• The study of low molecular weightThe study of low molecular weight
molecules (molecules (<1500 Da) or metabolitesor metabolites
found within cells and biological systemsfound within cells and biological systems
on global level (metabolome)on global level (metabolome)
• Measures changes downstream ofMeasures changes downstream of
genomic, transcriptomic and proteomicgenomic, transcriptomic and proteomic
alterations and, therefore, is consideredalterations and, therefore, is considered
more representative of the functionalmore representative of the functional
state of a cellstate of a cell
• Can measure hundreds to thousandsCan measure hundreds to thousands
of unique chemical entities providingof unique chemical entities providing
an overall understanding of metabolisman overall understanding of metabolism
• Metabolites are conserved acrossMetabolites are conserved across
various animal species, facilitating thevarious animal species, facilitating the
extrapolation of research findings inextrapolation of research findings in
laboratory animals to humanslaboratory animals to humans
• Is an integral part of system biologyIs an integral part of system biology
3077463-
1. Sample collection
2. Metabolite extraction
3. Metabolite separation
4. Metabolite identification
5. Data analysis and canonical pathway enrichment analysis (MPP, SIMCA-P, MetacoreTM
)
3077463-
Identification of Altered Metabolic Pathways in PlasmaIdentification of Altered Metabolic Pathways in Plasma
and CSF in Mild Cognitive Impairment and Alzheimer’sand CSF in Mild Cognitive Impairment and Alzheimer’s
Disease Using MetabolomicsDisease Using Metabolomics
E. Trushina, T. Dutta, X-M. T. Persson, M. M. Mielke, R. C. PetersenE. Trushina, T. Dutta, X-M. T. Persson, M. M. Mielke, R. C. Petersen
PLoS ONE 8(5): e63644.PLoS ONE 8(5): e63644.
Mayo Clinic Study of Aging and ADRC
CSF and
plasma
3077463-
PLASMAPLASMA CSFCSF
MCIvsCNMCIvsCNADvsCNADvsCNADvsMCIADvsMCI
plasmaplasmaCSFCSF
MCI
AD CN
MCI
AD CN
orthogonal two partial least squares-discriminant analysis (O2PLS-DA)
Unsupervised Principal Component Analysis (PCA)
3077463-
Plasma CSF
Lysine
Androstenedione and testosterone
TCA cycle
Saturated fatty acid
Mitochondrial ketone bodies
Estrone
Prostaglandin 2
Aminoacyl-tRNA BS in cytoplasm
Tryptophan
Leucine, isoleucine and valine
Neurophysiological process_
Melatonin signaling
Pyruvate
Serotonin-melatonin
GABA
Cholesterol
Phospholipid p. 1
Butanoate
Plasmalogen
Propionate
Pyruvate/rodent version
Phenylalanine
Polyamine
(L)-Arginine
TCA cycle
Nicotine MB in liver
Aldosterone
Seratonin-melatonin
Cortisone
Prostaglandin 2
Methionine-cysteine-glutamate
Aspartate and asparagine
Vitamin B6
Histidine-glutamate-glutamine
Arginine/rodent version
Tryptophan
Urea cycle
Ascorbate
Vitamin B7 (biotin)
Cholesterol
Sulfur
Alanine, (L)-cysteine, (L)-methionine
Pyruvate/rodent version
-log(p-value) -log(p-value)
Role of Diethylhexyl Phthalate and
Tributyltin in fat differentiation
6/85
3/41
3/51
3/69
2/27
2/35
3/94
3/97
3/101
2/42
2/43
2/49
2/51
2/53
2/54
2/61
2/63
2/64
2/66
2/66
2/67
2/68
2/76
7/51
7/56
5/41
5/51
5/56
6/94
4/43
5/73
3/30
5/95
5/97
5/101
4/70
2/18
3/47
4/88
3/52
3/56
2/29
3/66
Metabolic changes in MCI vs. CNMetabolic changes in MCI vs. CN
3077463-
Plasma CSF
-log(p-value) -log(p-value)
Cholesterol and sphingolipids transport
Vitamin D2
Polyamine
Intracellular cholesterol transport
(L)-Arginine
Beta-alanine
Aspartate and aspargine
Cortisone
Galactose
Lipid metabolism
FXR-regulated cholesterol and bile acid transport
Glycolysis and gluconeogenesis
Cholesterol
Bile acid
Regulation of CFTR gating
Role of VDR in regulation of genes involved in osteoporosis
Vitamin D3 metabolic C-23 and C-24 pathways
Triacylglycerol BS in obesity and diabetes mellitus, type II
Muscle contraction_nNOS signaling in skeletal muscles
Niacin-HDL
Aminoacyl-tRNA biosynthesis in mitochondria
Triacylglycerol metabolism p.2
Urea cycle
Lysine
TCA cycle
Prostaglandin 2
Aminoacyl-tRNA BS in cytoplasm
Androstenedione and testosterone
Alanine, (L)-cysteine, (L)-methionine
Mechanism of action of DGAT1 in obesity and diabetes mellitus, type II
Methionine-cysteine-glutamate
Cortisol BS from cholesterol
Regulation of lipid MB_FXR-dependent negative-feedback regulation of
bile acid concentration
Riboflavin
Acetylcholine
Fructose
Tryptophan
Development_Activation of astroglia cell proliferation by ACM3
Fatty Acid Omega Oxidation
Methionine
Cholesterol and sphingolipids transport
Intracellular cholesterol transport
(L)-Arginine
Histidine-glutamate-glutamine
Aspartate and aspargine
Cortisone
Ascorbate
Mitochondrial ketone bodies
Nicotine metabolism in liver
Glycolysis and gluconeogenesis
Cholesterol and sphingolipids transport/transport from Golgi
Bile acid
Regulation of CFTR gating
HETE and HPETE
FXR-regulated cholesterol and bile acid cellular
transport Pyruvate
Propionate
Urea cycle
Estrone
TCA cycle
Prostaglandin 2
Saturated fatty acids
Serotonin-melatonin
UMP
(L)-Alanine, (L)-cysteine, (L)-methionine
Cortisol BS from cholesterol
GABA
Glycine, serine, cysteine and threonine
Beta-Alanine
Tryptophan
8/20
7/38
9/68
9/70
9/90
8/76
5/35
7/73
8/94
6/56
6/59
6/59
5/41
8/20
7/85
5/46
7/88
7/94
4/33
4/35
3/20
4/41 5/56
3/24 6/80
4/47
6/94
5/66
3/28 3/27
5/74
5/69
5/66
3/31
3/31
7/123
2/14
3/33
3/34
3/31
5/42
5/56
5/61
3/24
4/43
3/28
6/97
6/101
3/32
3/34
4/51
13/94
8/51
9/73
8/70
9/90
8/76
4/18
5/33
6/51
6/56
5/41
4/32
7/94
4/42
6/95
6/101
4/53
4/56
3/35
3077463-
Differentiating pathwaysDifferentiating pathways
3077463-
ConclusionsConclusions
• Metabolomics offers novel approach to identify alterations in multiple
biochemical networks over the course of AD
• It allows identification of both expected and non-expected changes in
biochemical pathways in animal models of AD and in human samples
• Metabolic signatures in CSF and plasma correlate with AD severity
• Metabolic signatures in plasma accurately reflect changes in CSF:
MCI: 30% of the pathways altered in CSF and plasma were the same
AD: 60% of the pathways affected in CSF and plasma were the same
• Application of metabolomics in conjunction with other currently available
tests could increase early AD diagnosis
• Metabolomics could be conducted in readily available fluids such as blood
making it attractive for clinical application
3077463-1
Future DirectionsFuture Directions
• Studies in larger patient cohorts are needed
• Test and sample validation studies need to be included in every project
• Acquisition of the data using multiple analytical platforms should increase
the accuracy and reproducibility
• Additional research is needed to reveal the role of metabolites linked
to AD pathology in the mechanisms of normal aging

Más contenido relacionado

La actualidad más candente

Research Paper - Ayla Kanber
Research Paper - Ayla KanberResearch Paper - Ayla Kanber
Research Paper - Ayla KanberAyla Kanber
 
Autophagy the housekeeper in every cell
Autophagy the housekeeper in every cellAutophagy the housekeeper in every cell
Autophagy the housekeeper in every cellfathi neana
 
M. Celeste Simón-Homenaje al bioquímico español Alberto Sols
M. Celeste Simón-Homenaje al bioquímico español Alberto SolsM. Celeste Simón-Homenaje al bioquímico español Alberto Sols
M. Celeste Simón-Homenaje al bioquímico español Alberto SolsFundación Ramón Areces
 
¹³C Isotope Tracing to Delineate Altered Choline Metabolism in Proliferating ...
¹³C Isotope Tracing to Delineate Altered Choline Metabolism in Proliferating ...¹³C Isotope Tracing to Delineate Altered Choline Metabolism in Proliferating ...
¹³C Isotope Tracing to Delineate Altered Choline Metabolism in Proliferating ...ShreyaMandal4
 
Enzyme specificity types and applications
Enzyme specificity types and applicationsEnzyme specificity types and applications
Enzyme specificity types and applicationsrohini sane
 
Biological time keeper linked to diabetes and obesity
Biological time keeper linked to diabetes and obesityBiological time keeper linked to diabetes and obesity
Biological time keeper linked to diabetes and obesityAdonis Sfera, MD
 
Patten DA et al. - EMBO J - 2014
Patten DA et al. - EMBO J - 2014Patten DA et al. - EMBO J - 2014
Patten DA et al. - EMBO J - 2014Jacob Wong
 
Haley Discovery Day Poster (1)
Haley Discovery Day Poster (1)Haley Discovery Day Poster (1)
Haley Discovery Day Poster (1)Haley Porter
 
Antihypertensive Peptides; Synthesis, Properties and Application in Foods
Antihypertensive Peptides; Synthesis, Properties and Application in FoodsAntihypertensive Peptides; Synthesis, Properties and Application in Foods
Antihypertensive Peptides; Synthesis, Properties and Application in FoodsAkshay Ramani
 
Study on In Vitro Kinetic Characterization of Transporter-Mediated Permeability
Study on In Vitro Kinetic Characterization of Transporter-Mediated PermeabilityStudy on In Vitro Kinetic Characterization of Transporter-Mediated Permeability
Study on In Vitro Kinetic Characterization of Transporter-Mediated PermeabilityTorben Haagh
 
Poster 13 12 15-Valérie Vilmont-P116-final
Poster 13 12 15-Valérie Vilmont-P116-finalPoster 13 12 15-Valérie Vilmont-P116-final
Poster 13 12 15-Valérie Vilmont-P116-finalVal Vilmont
 
Tetrameric peptide purified from hydrolysates of biodiesel byproducts of nann...
Tetrameric peptide purified from hydrolysates of biodiesel byproducts of nann...Tetrameric peptide purified from hydrolysates of biodiesel byproducts of nann...
Tetrameric peptide purified from hydrolysates of biodiesel byproducts of nann...Van-Tinh Nguyen
 
PPAR alpha final research paper
PPAR alpha final research paperPPAR alpha final research paper
PPAR alpha final research paperEric Cobb
 
Proteolysis-targeting chimeras as tools in drug development (i)
Proteolysis-targeting chimeras as tools in drug development (i)Proteolysis-targeting chimeras as tools in drug development (i)
Proteolysis-targeting chimeras as tools in drug development (i)creativebiolabs11
 

La actualidad más candente (20)

Research Paper - Ayla Kanber
Research Paper - Ayla KanberResearch Paper - Ayla Kanber
Research Paper - Ayla Kanber
 
Autophagy the housekeeper in every cell
Autophagy the housekeeper in every cellAutophagy the housekeeper in every cell
Autophagy the housekeeper in every cell
 
M. Celeste Simón-Homenaje al bioquímico español Alberto Sols
M. Celeste Simón-Homenaje al bioquímico español Alberto SolsM. Celeste Simón-Homenaje al bioquímico español Alberto Sols
M. Celeste Simón-Homenaje al bioquímico español Alberto Sols
 
¹³C Isotope Tracing to Delineate Altered Choline Metabolism in Proliferating ...
¹³C Isotope Tracing to Delineate Altered Choline Metabolism in Proliferating ...¹³C Isotope Tracing to Delineate Altered Choline Metabolism in Proliferating ...
¹³C Isotope Tracing to Delineate Altered Choline Metabolism in Proliferating ...
 
Enzyme specificity types and applications
Enzyme specificity types and applicationsEnzyme specificity types and applications
Enzyme specificity types and applications
 
Biological time keeper linked to diabetes and obesity
Biological time keeper linked to diabetes and obesityBiological time keeper linked to diabetes and obesity
Biological time keeper linked to diabetes and obesity
 
Patten DA et al. - EMBO J - 2014
Patten DA et al. - EMBO J - 2014Patten DA et al. - EMBO J - 2014
Patten DA et al. - EMBO J - 2014
 
Haley Discovery Day Poster (1)
Haley Discovery Day Poster (1)Haley Discovery Day Poster (1)
Haley Discovery Day Poster (1)
 
Antihypertensive Peptides; Synthesis, Properties and Application in Foods
Antihypertensive Peptides; Synthesis, Properties and Application in FoodsAntihypertensive Peptides; Synthesis, Properties and Application in Foods
Antihypertensive Peptides; Synthesis, Properties and Application in Foods
 
I0342048053
I0342048053I0342048053
I0342048053
 
ASCB poster
ASCB posterASCB poster
ASCB poster
 
Study on In Vitro Kinetic Characterization of Transporter-Mediated Permeability
Study on In Vitro Kinetic Characterization of Transporter-Mediated PermeabilityStudy on In Vitro Kinetic Characterization of Transporter-Mediated Permeability
Study on In Vitro Kinetic Characterization of Transporter-Mediated Permeability
 
Poster 13 12 15-Valérie Vilmont-P116-final
Poster 13 12 15-Valérie Vilmont-P116-finalPoster 13 12 15-Valérie Vilmont-P116-final
Poster 13 12 15-Valérie Vilmont-P116-final
 
Tetrameric peptide purified from hydrolysates of biodiesel byproducts of nann...
Tetrameric peptide purified from hydrolysates of biodiesel byproducts of nann...Tetrameric peptide purified from hydrolysates of biodiesel byproducts of nann...
Tetrameric peptide purified from hydrolysates of biodiesel byproducts of nann...
 
1 Lactaptin
1 Lactaptin1 Lactaptin
1 Lactaptin
 
B0343014018
B0343014018B0343014018
B0343014018
 
BBRC pcsk9
BBRC pcsk9BBRC pcsk9
BBRC pcsk9
 
PPARs
PPARsPPARs
PPARs
 
PPAR alpha final research paper
PPAR alpha final research paperPPAR alpha final research paper
PPAR alpha final research paper
 
Proteolysis-targeting chimeras as tools in drug development (i)
Proteolysis-targeting chimeras as tools in drug development (i)Proteolysis-targeting chimeras as tools in drug development (i)
Proteolysis-targeting chimeras as tools in drug development (i)
 

Destacado

Scb alzforum
Scb alzforumScb alzforum
Scb alzforumAlzforum
 
Zetterberg plasmatau2013
Zetterberg plasmatau2013Zetterberg plasmatau2013
Zetterberg plasmatau2013Alzforum
 
Alz forum lovestone (short)
Alz forum lovestone (short)Alz forum lovestone (short)
Alz forum lovestone (short)Alzforum
 
Alzforum blood based biomarkers hf final
Alzforum blood based biomarkers hf finalAlzforum blood based biomarkers hf final
Alzforum blood based biomarkers hf finalAlzforum
 
O'bryant alz forum presentation 6.13.13
O'bryant alz forum presentation 6.13.13O'bryant alz forum presentation 6.13.13
O'bryant alz forum presentation 6.13.13Alzforum
 
Bob Olsson - Alzforum Live Webinar April 29, 2016
Bob Olsson - Alzforum Live Webinar April 29, 2016Bob Olsson - Alzforum Live Webinar April 29, 2016
Bob Olsson - Alzforum Live Webinar April 29, 2016Alzforum
 
Johannes Streffer - Alzforum webinar April 29, 2016
Johannes Streffer - Alzforum webinar April 29, 2016Johannes Streffer - Alzforum webinar April 29, 2016
Johannes Streffer - Alzforum webinar April 29, 2016Alzforum
 
Henrik Zetterberg - Alzforum webinar April 29, 2016
Henrik Zetterberg - Alzforum webinar April 29, 2016Henrik Zetterberg - Alzforum webinar April 29, 2016
Henrik Zetterberg - Alzforum webinar April 29, 2016Alzforum
 
Neurovascular Regulation in Health and Disease
Neurovascular Regulation in Health and DiseaseNeurovascular Regulation in Health and Disease
Neurovascular Regulation in Health and DiseaseAlzforum
 
The Glymphatic System – A New Player in Alzheimer Disease?
The Glymphatic System – A New Player  in Alzheimer Disease?The Glymphatic System – A New Player  in Alzheimer Disease?
The Glymphatic System – A New Player in Alzheimer Disease?Alzforum
 

Destacado (10)

Scb alzforum
Scb alzforumScb alzforum
Scb alzforum
 
Zetterberg plasmatau2013
Zetterberg plasmatau2013Zetterberg plasmatau2013
Zetterberg plasmatau2013
 
Alz forum lovestone (short)
Alz forum lovestone (short)Alz forum lovestone (short)
Alz forum lovestone (short)
 
Alzforum blood based biomarkers hf final
Alzforum blood based biomarkers hf finalAlzforum blood based biomarkers hf final
Alzforum blood based biomarkers hf final
 
O'bryant alz forum presentation 6.13.13
O'bryant alz forum presentation 6.13.13O'bryant alz forum presentation 6.13.13
O'bryant alz forum presentation 6.13.13
 
Bob Olsson - Alzforum Live Webinar April 29, 2016
Bob Olsson - Alzforum Live Webinar April 29, 2016Bob Olsson - Alzforum Live Webinar April 29, 2016
Bob Olsson - Alzforum Live Webinar April 29, 2016
 
Johannes Streffer - Alzforum webinar April 29, 2016
Johannes Streffer - Alzforum webinar April 29, 2016Johannes Streffer - Alzforum webinar April 29, 2016
Johannes Streffer - Alzforum webinar April 29, 2016
 
Henrik Zetterberg - Alzforum webinar April 29, 2016
Henrik Zetterberg - Alzforum webinar April 29, 2016Henrik Zetterberg - Alzforum webinar April 29, 2016
Henrik Zetterberg - Alzforum webinar April 29, 2016
 
Neurovascular Regulation in Health and Disease
Neurovascular Regulation in Health and DiseaseNeurovascular Regulation in Health and Disease
Neurovascular Regulation in Health and Disease
 
The Glymphatic System – A New Player in Alzheimer Disease?
The Glymphatic System – A New Player  in Alzheimer Disease?The Glymphatic System – A New Player  in Alzheimer Disease?
The Glymphatic System – A New Player in Alzheimer Disease?
 

Similar a ARF webinar trushina

Personalized & Translational Medicine - KineMed, Inc. - Marc Hellerstein, MD,...
Personalized & Translational Medicine - KineMed, Inc. - Marc Hellerstein, MD,...Personalized & Translational Medicine - KineMed, Inc. - Marc Hellerstein, MD,...
Personalized & Translational Medicine - KineMed, Inc. - Marc Hellerstein, MD,...KineMed, Inc.
 
Discovery Day 2014 Final Poster - JP
Discovery Day 2014 Final Poster - JPDiscovery Day 2014 Final Poster - JP
Discovery Day 2014 Final Poster - JPJustin Pezick
 
Linking t rna localization with activation
Linking t rna localization with activationLinking t rna localization with activation
Linking t rna localization with activationJoy Maria Mitchell
 
Non biopsy diagnosis of acute rejection of Renal allograft
  Non biopsy diagnosis of acute rejection of Renal allograft  Non biopsy diagnosis of acute rejection of Renal allograft
Non biopsy diagnosis of acute rejection of Renal allograftBakshish Singh
 
Comprehensive assessment of chamber-specific and transmural heterogeneity in ...
Comprehensive assessment of chamber-specific and transmural heterogeneity in ...Comprehensive assessment of chamber-specific and transmural heterogeneity in ...
Comprehensive assessment of chamber-specific and transmural heterogeneity in ...Justin Doop
 
Metabolism of stability studies and sub cellular fractions
Metabolism of stability studies and sub cellular fractionsMetabolism of stability studies and sub cellular fractions
Metabolism of stability studies and sub cellular fractionsManjunatha D C
 
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...Norwich Research Park
 
FA 2022.pdf
FA 2022.pdfFA 2022.pdf
FA 2022.pdfHCmPhng1
 
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...Gul Muneer
 
Describe The Structure Of Methanogenesis
Describe The Structure Of MethanogenesisDescribe The Structure Of Methanogenesis
Describe The Structure Of MethanogenesisTammy Kordeliski
 
Dissertation final complete1
Dissertation final complete1Dissertation final complete1
Dissertation final complete1Patrick Newton
 
Metabolomics
MetabolomicsMetabolomics
Metabolomicspriya1111
 

Similar a ARF webinar trushina (20)

Personalized & Translational Medicine - KineMed, Inc. - Marc Hellerstein, MD,...
Personalized & Translational Medicine - KineMed, Inc. - Marc Hellerstein, MD,...Personalized & Translational Medicine - KineMed, Inc. - Marc Hellerstein, MD,...
Personalized & Translational Medicine - KineMed, Inc. - Marc Hellerstein, MD,...
 
Discovery Day 2014 Final Poster - JP
Discovery Day 2014 Final Poster - JPDiscovery Day 2014 Final Poster - JP
Discovery Day 2014 Final Poster - JP
 
Senior Thesis- Poster
Senior Thesis- PosterSenior Thesis- Poster
Senior Thesis- Poster
 
Linking t rna localization with activation
Linking t rna localization with activationLinking t rna localization with activation
Linking t rna localization with activation
 
Mod 5 Poster
Mod 5 PosterMod 5 Poster
Mod 5 Poster
 
articulo
articulo articulo
articulo
 
Non biopsy diagnosis of acute rejection of Renal allograft
  Non biopsy diagnosis of acute rejection of Renal allograft  Non biopsy diagnosis of acute rejection of Renal allograft
Non biopsy diagnosis of acute rejection of Renal allograft
 
Comprehensive assessment of chamber-specific and transmural heterogeneity in ...
Comprehensive assessment of chamber-specific and transmural heterogeneity in ...Comprehensive assessment of chamber-specific and transmural heterogeneity in ...
Comprehensive assessment of chamber-specific and transmural heterogeneity in ...
 
Transporters
TransportersTransporters
Transporters
 
Metabolism of stability studies and sub cellular fractions
Metabolism of stability studies and sub cellular fractionsMetabolism of stability studies and sub cellular fractions
Metabolism of stability studies and sub cellular fractions
 
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
 
FA 2022.pdf
FA 2022.pdfFA 2022.pdf
FA 2022.pdf
 
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...
 
Jsi 124 pathway
Jsi 124 pathwayJsi 124 pathway
Jsi 124 pathway
 
Describe The Structure Of Methanogenesis
Describe The Structure Of MethanogenesisDescribe The Structure Of Methanogenesis
Describe The Structure Of Methanogenesis
 
Enzymes in liver disorders presentation with cases
Enzymes in liver disorders presentation  with casesEnzymes in liver disorders presentation  with cases
Enzymes in liver disorders presentation with cases
 
Dissertation final complete1
Dissertation final complete1Dissertation final complete1
Dissertation final complete1
 
Metabolomics
MetabolomicsMetabolomics
Metabolomics
 
Lysine Crotonylation.pptx
Lysine Crotonylation.pptxLysine Crotonylation.pptx
Lysine Crotonylation.pptx
 
Dr. Goy MCL
Dr. Goy MCLDr. Goy MCL
Dr. Goy MCL
 

Más de Alzforum

First Identification of Role TMEM106B in FTD
First Identification of Role TMEM106B in FTDFirst Identification of Role TMEM106B in FTD
First Identification of Role TMEM106B in FTDAlzforum
 
Protein-RNA Complexes, ALS and Aging
Protein-RNA Complexes, ALS and AgingProtein-RNA Complexes, ALS and Aging
Protein-RNA Complexes, ALS and AgingAlzforum
 
Lifespan vs. Healthspan
Lifespan vs. HealthspanLifespan vs. Healthspan
Lifespan vs. HealthspanAlzforum
 
Genetic regulation of human brain aging
Genetic regulation of human brain agingGenetic regulation of human brain aging
Genetic regulation of human brain agingAlzforum
 
Marc Dhenain Alzforum Webinar - Dec 7, 2016
Marc Dhenain Alzforum Webinar - Dec 7, 2016Marc Dhenain Alzforum Webinar - Dec 7, 2016
Marc Dhenain Alzforum Webinar - Dec 7, 2016Alzforum
 
Peter Nelson Alzforum Webinar - Dec 7, 2016
Peter Nelson Alzforum Webinar - Dec 7, 2016Peter Nelson Alzforum Webinar - Dec 7, 2016
Peter Nelson Alzforum Webinar - Dec 7, 2016Alzforum
 
Elizabeth Head Alzforum Webinar - Dec 7, 2016
Elizabeth Head Alzforum Webinar - Dec 7, 2016Elizabeth Head Alzforum Webinar - Dec 7, 2016
Elizabeth Head Alzforum Webinar - Dec 7, 2016Alzforum
 
Patrick Hof Alzforum Webinar - Dec 7, 2016
Patrick Hof Alzforum Webinar - Dec 7, 2016Patrick Hof Alzforum Webinar - Dec 7, 2016
Patrick Hof Alzforum Webinar - Dec 7, 2016Alzforum
 
Lary Walker Introduction Webinar
Lary Walker Introduction WebinarLary Walker Introduction Webinar
Lary Walker Introduction WebinarAlzforum
 
Byron Caughey
Byron CaugheyByron Caughey
Byron CaugheyAlzforum
 
Dominic Walsh - A Critical Appraisal of the Pathogenic Protein Spread Hypothe...
Dominic Walsh - A Critical Appraisal of the Pathogenic Protein Spread Hypothe...Dominic Walsh - A Critical Appraisal of the Pathogenic Protein Spread Hypothe...
Dominic Walsh - A Critical Appraisal of the Pathogenic Protein Spread Hypothe...Alzforum
 
David Harris -
David Harris - David Harris -
David Harris - Alzforum
 
Patrik Brundin - Are Synucleinopathies Prion Diseases?
Patrik Brundin - Are Synucleinopathies Prion Diseases?Patrik Brundin - Are Synucleinopathies Prion Diseases?
Patrik Brundin - Are Synucleinopathies Prion Diseases?Alzforum
 
Virginia Lee - Cell-to-Cell Spread of Pathological Tau
Virginia Lee - Cell-to-Cell Spread of Pathological TauVirginia Lee - Cell-to-Cell Spread of Pathological Tau
Virginia Lee - Cell-to-Cell Spread of Pathological TauAlzforum
 
The cellular phase of Alzheimer's disease
The cellular phase of Alzheimer's diseaseThe cellular phase of Alzheimer's disease
The cellular phase of Alzheimer's diseaseAlzforum
 
Hendrix 2015 composite endpoints redacted
Hendrix 2015 composite endpoints redacted Hendrix 2015 composite endpoints redacted
Hendrix 2015 composite endpoints redacted Alzforum
 
Cliff Brangwynne
Cliff BrangwynneCliff Brangwynne
Cliff BrangwynneAlzforum
 
Paul Taylor
Paul Taylor Paul Taylor
Paul Taylor Alzforum
 
Markus Zweckstetter
Markus ZweckstetterMarkus Zweckstetter
Markus ZweckstetterAlzforum
 
Simon Alberti
Simon AlbertiSimon Alberti
Simon AlbertiAlzforum
 

Más de Alzforum (20)

First Identification of Role TMEM106B in FTD
First Identification of Role TMEM106B in FTDFirst Identification of Role TMEM106B in FTD
First Identification of Role TMEM106B in FTD
 
Protein-RNA Complexes, ALS and Aging
Protein-RNA Complexes, ALS and AgingProtein-RNA Complexes, ALS and Aging
Protein-RNA Complexes, ALS and Aging
 
Lifespan vs. Healthspan
Lifespan vs. HealthspanLifespan vs. Healthspan
Lifespan vs. Healthspan
 
Genetic regulation of human brain aging
Genetic regulation of human brain agingGenetic regulation of human brain aging
Genetic regulation of human brain aging
 
Marc Dhenain Alzforum Webinar - Dec 7, 2016
Marc Dhenain Alzforum Webinar - Dec 7, 2016Marc Dhenain Alzforum Webinar - Dec 7, 2016
Marc Dhenain Alzforum Webinar - Dec 7, 2016
 
Peter Nelson Alzforum Webinar - Dec 7, 2016
Peter Nelson Alzforum Webinar - Dec 7, 2016Peter Nelson Alzforum Webinar - Dec 7, 2016
Peter Nelson Alzforum Webinar - Dec 7, 2016
 
Elizabeth Head Alzforum Webinar - Dec 7, 2016
Elizabeth Head Alzforum Webinar - Dec 7, 2016Elizabeth Head Alzforum Webinar - Dec 7, 2016
Elizabeth Head Alzforum Webinar - Dec 7, 2016
 
Patrick Hof Alzforum Webinar - Dec 7, 2016
Patrick Hof Alzforum Webinar - Dec 7, 2016Patrick Hof Alzforum Webinar - Dec 7, 2016
Patrick Hof Alzforum Webinar - Dec 7, 2016
 
Lary Walker Introduction Webinar
Lary Walker Introduction WebinarLary Walker Introduction Webinar
Lary Walker Introduction Webinar
 
Byron Caughey
Byron CaugheyByron Caughey
Byron Caughey
 
Dominic Walsh - A Critical Appraisal of the Pathogenic Protein Spread Hypothe...
Dominic Walsh - A Critical Appraisal of the Pathogenic Protein Spread Hypothe...Dominic Walsh - A Critical Appraisal of the Pathogenic Protein Spread Hypothe...
Dominic Walsh - A Critical Appraisal of the Pathogenic Protein Spread Hypothe...
 
David Harris -
David Harris - David Harris -
David Harris -
 
Patrik Brundin - Are Synucleinopathies Prion Diseases?
Patrik Brundin - Are Synucleinopathies Prion Diseases?Patrik Brundin - Are Synucleinopathies Prion Diseases?
Patrik Brundin - Are Synucleinopathies Prion Diseases?
 
Virginia Lee - Cell-to-Cell Spread of Pathological Tau
Virginia Lee - Cell-to-Cell Spread of Pathological TauVirginia Lee - Cell-to-Cell Spread of Pathological Tau
Virginia Lee - Cell-to-Cell Spread of Pathological Tau
 
The cellular phase of Alzheimer's disease
The cellular phase of Alzheimer's diseaseThe cellular phase of Alzheimer's disease
The cellular phase of Alzheimer's disease
 
Hendrix 2015 composite endpoints redacted
Hendrix 2015 composite endpoints redacted Hendrix 2015 composite endpoints redacted
Hendrix 2015 composite endpoints redacted
 
Cliff Brangwynne
Cliff BrangwynneCliff Brangwynne
Cliff Brangwynne
 
Paul Taylor
Paul Taylor Paul Taylor
Paul Taylor
 
Markus Zweckstetter
Markus ZweckstetterMarkus Zweckstetter
Markus Zweckstetter
 
Simon Alberti
Simon AlbertiSimon Alberti
Simon Alberti
 

Último

Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 

Último (20)

Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 

ARF webinar trushina

  • 1. 3077463- Metabolomics-based translationalMetabolomics-based translational biomarkers for Alzheimer’s Diseasebiomarkers for Alzheimer’s Disease Eugenia Trushina, PhDEugenia Trushina, PhD Mayo Clinic RochesterMayo Clinic Rochester June 17, 2013June 17, 2013
  • 2. 3077463- MetabolomicsMetabolomics • The study of low molecular weightThe study of low molecular weight molecules (molecules (<1500 Da) or metabolitesor metabolites found within cells and biological systemsfound within cells and biological systems on global level (metabolome)on global level (metabolome) • Measures changes downstream ofMeasures changes downstream of genomic, transcriptomic and proteomicgenomic, transcriptomic and proteomic alterations and, therefore, is consideredalterations and, therefore, is considered more representative of the functionalmore representative of the functional state of a cellstate of a cell • Can measure hundreds to thousandsCan measure hundreds to thousands of unique chemical entities providingof unique chemical entities providing an overall understanding of metabolisman overall understanding of metabolism • Metabolites are conserved acrossMetabolites are conserved across various animal species, facilitating thevarious animal species, facilitating the extrapolation of research findings inextrapolation of research findings in laboratory animals to humanslaboratory animals to humans • Is an integral part of system biologyIs an integral part of system biology
  • 3. 3077463- 1. Sample collection 2. Metabolite extraction 3. Metabolite separation 4. Metabolite identification 5. Data analysis and canonical pathway enrichment analysis (MPP, SIMCA-P, MetacoreTM )
  • 4. 3077463- Identification of Altered Metabolic Pathways in PlasmaIdentification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’sand CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using MetabolomicsDisease Using Metabolomics E. Trushina, T. Dutta, X-M. T. Persson, M. M. Mielke, R. C. PetersenE. Trushina, T. Dutta, X-M. T. Persson, M. M. Mielke, R. C. Petersen PLoS ONE 8(5): e63644.PLoS ONE 8(5): e63644. Mayo Clinic Study of Aging and ADRC CSF and plasma
  • 5. 3077463- PLASMAPLASMA CSFCSF MCIvsCNMCIvsCNADvsCNADvsCNADvsMCIADvsMCI plasmaplasmaCSFCSF MCI AD CN MCI AD CN orthogonal two partial least squares-discriminant analysis (O2PLS-DA) Unsupervised Principal Component Analysis (PCA)
  • 6. 3077463- Plasma CSF Lysine Androstenedione and testosterone TCA cycle Saturated fatty acid Mitochondrial ketone bodies Estrone Prostaglandin 2 Aminoacyl-tRNA BS in cytoplasm Tryptophan Leucine, isoleucine and valine Neurophysiological process_ Melatonin signaling Pyruvate Serotonin-melatonin GABA Cholesterol Phospholipid p. 1 Butanoate Plasmalogen Propionate Pyruvate/rodent version Phenylalanine Polyamine (L)-Arginine TCA cycle Nicotine MB in liver Aldosterone Seratonin-melatonin Cortisone Prostaglandin 2 Methionine-cysteine-glutamate Aspartate and asparagine Vitamin B6 Histidine-glutamate-glutamine Arginine/rodent version Tryptophan Urea cycle Ascorbate Vitamin B7 (biotin) Cholesterol Sulfur Alanine, (L)-cysteine, (L)-methionine Pyruvate/rodent version -log(p-value) -log(p-value) Role of Diethylhexyl Phthalate and Tributyltin in fat differentiation 6/85 3/41 3/51 3/69 2/27 2/35 3/94 3/97 3/101 2/42 2/43 2/49 2/51 2/53 2/54 2/61 2/63 2/64 2/66 2/66 2/67 2/68 2/76 7/51 7/56 5/41 5/51 5/56 6/94 4/43 5/73 3/30 5/95 5/97 5/101 4/70 2/18 3/47 4/88 3/52 3/56 2/29 3/66 Metabolic changes in MCI vs. CNMetabolic changes in MCI vs. CN
  • 7. 3077463- Plasma CSF -log(p-value) -log(p-value) Cholesterol and sphingolipids transport Vitamin D2 Polyamine Intracellular cholesterol transport (L)-Arginine Beta-alanine Aspartate and aspargine Cortisone Galactose Lipid metabolism FXR-regulated cholesterol and bile acid transport Glycolysis and gluconeogenesis Cholesterol Bile acid Regulation of CFTR gating Role of VDR in regulation of genes involved in osteoporosis Vitamin D3 metabolic C-23 and C-24 pathways Triacylglycerol BS in obesity and diabetes mellitus, type II Muscle contraction_nNOS signaling in skeletal muscles Niacin-HDL Aminoacyl-tRNA biosynthesis in mitochondria Triacylglycerol metabolism p.2 Urea cycle Lysine TCA cycle Prostaglandin 2 Aminoacyl-tRNA BS in cytoplasm Androstenedione and testosterone Alanine, (L)-cysteine, (L)-methionine Mechanism of action of DGAT1 in obesity and diabetes mellitus, type II Methionine-cysteine-glutamate Cortisol BS from cholesterol Regulation of lipid MB_FXR-dependent negative-feedback regulation of bile acid concentration Riboflavin Acetylcholine Fructose Tryptophan Development_Activation of astroglia cell proliferation by ACM3 Fatty Acid Omega Oxidation Methionine Cholesterol and sphingolipids transport Intracellular cholesterol transport (L)-Arginine Histidine-glutamate-glutamine Aspartate and aspargine Cortisone Ascorbate Mitochondrial ketone bodies Nicotine metabolism in liver Glycolysis and gluconeogenesis Cholesterol and sphingolipids transport/transport from Golgi Bile acid Regulation of CFTR gating HETE and HPETE FXR-regulated cholesterol and bile acid cellular transport Pyruvate Propionate Urea cycle Estrone TCA cycle Prostaglandin 2 Saturated fatty acids Serotonin-melatonin UMP (L)-Alanine, (L)-cysteine, (L)-methionine Cortisol BS from cholesterol GABA Glycine, serine, cysteine and threonine Beta-Alanine Tryptophan 8/20 7/38 9/68 9/70 9/90 8/76 5/35 7/73 8/94 6/56 6/59 6/59 5/41 8/20 7/85 5/46 7/88 7/94 4/33 4/35 3/20 4/41 5/56 3/24 6/80 4/47 6/94 5/66 3/28 3/27 5/74 5/69 5/66 3/31 3/31 7/123 2/14 3/33 3/34 3/31 5/42 5/56 5/61 3/24 4/43 3/28 6/97 6/101 3/32 3/34 4/51 13/94 8/51 9/73 8/70 9/90 8/76 4/18 5/33 6/51 6/56 5/41 4/32 7/94 4/42 6/95 6/101 4/53 4/56 3/35
  • 9. 3077463- ConclusionsConclusions • Metabolomics offers novel approach to identify alterations in multiple biochemical networks over the course of AD • It allows identification of both expected and non-expected changes in biochemical pathways in animal models of AD and in human samples • Metabolic signatures in CSF and plasma correlate with AD severity • Metabolic signatures in plasma accurately reflect changes in CSF: MCI: 30% of the pathways altered in CSF and plasma were the same AD: 60% of the pathways affected in CSF and plasma were the same • Application of metabolomics in conjunction with other currently available tests could increase early AD diagnosis • Metabolomics could be conducted in readily available fluids such as blood making it attractive for clinical application
  • 10. 3077463-1 Future DirectionsFuture Directions • Studies in larger patient cohorts are needed • Test and sample validation studies need to be included in every project • Acquisition of the data using multiple analytical platforms should increase the accuracy and reproducibility • Additional research is needed to reveal the role of metabolites linked to AD pathology in the mechanisms of normal aging

Notas del editor

  1. 15 cognitively normal (CN), 15 amnestic mild cognitive impairment (MCI), 15 AD UPLC – TOF-MS – based non-targeted metabolomics approach Patients were enrolled and followed in the Mayo Clinic population-based epidemiologic study of normal aging, MCSA, and Mayo Clinic Alzheimer’s Disease Research Center (ADRC).
  2. Acetylcholine, noradrenalin, dopamine and serotonin neurotransmitter systems are primarily affected in AD with subsequent loss of associated neurons ( 42 ). Consistent with that, we have found prominent, early changes in tryptophan biosynthesis in both CSF and plasma of MCI and AD patients (Fig. 3-5). Tryptophan is a precursor for serotonin, melatonin, and niacin synthesis ( 43-45 ). We also found alterations in the serotonin/melatonin pathway in CSF of both MCI and AD patients, and in plasma of MCI individuals (Fig. 3,4). These data are in agreement with recent studies indicating that loss of serotonergic neurons correlates with AD severity, memory impairment, and neuropsychiatric symptoms
  3. Disorder in the hypothalamic-pituitary-adrenal (HPA) axis with increased cortisol levels in CSF and plasma is also well established for AD patients; and increased cortisol levels in CSF from AD patients have been recently demonstrated using metabolomic profiling [30]. Our data confirmed that the pathway related to the cortisol biosynthesis from cholesterol was significantly affected in both CSF and plasma from AD patients (Fig. 5). However, we also found that cortisone biosynthesis and metabolism was among the pathways that, along with PGE2, most accurately separated the clinical groups in CSF (Fig. 6). Among pathways that were uniquely affected in plasma of AD patients were those related to obesity and type II diabetes mellitus (Fig. 5). This is an important observation taking in consideration the data demonstrating that type II diabetes mellitus is associated with an increased risk of cognitive dysfunction and dementia, and needs to be explored in future studies [71] Moreover, our study identified CSF PGE2 biosynthesis and metabolism as one of the key pathways that varied with AD severity (Fig. 7). Implication of PGE2 in neural injury in AD is well documented, and includes modulation of protein-lipid interactions, trans-membrane and trans-synaptic signaling [69]. It was shown that levels of PGE2 measured in the CSF of control, MCI and AD patients enrolled in the longitudinal study inversely correlate with AD severity: PGE2 was higher in patients with mild memory impairment, but lower in those with more advanced AD [70].